NEK2 and cancer: Although several NEK2 inhibitors and nucleic acid medicines targeting NEK2 have demonstrated preliminary therapeutic effectiveness against cancer cells both in vitro and in vivo, no NEK2 inhibitors have so far undergone clinical trials [10, 54].